Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M161,846Revenue (TTM) $M39,385Net Margin (%)11.7Altman Z-Score3.2
Enterprise Value $M174,767EPS (TTM) $1.6Operating Margin %18.4Piotroski F-Score7
P/E(ttm)36.1Beneish M-Score-2.8Pre-tax Margin (%)14.3Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %3.8Quick Ratio1.4Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %9.2Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow15.2y-y EBITDA Growth Rate %-45.4ROA % (ttm)4.5Higher Current Ratio y-yY
Dividend Yield %3.1PEG4.0ROE % (ttm)10.1Less Shares Outstanding y-yY
Payout Ratio %112Shares Outstanding M2,768ROIC % (ttm)10.6Gross Margin Increase y-yY

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKT Rowe Price Equity Income Fund 2016-06-30 Reduce-0.3%$52.91 - $57.68
($55.73)
$ 58.826%Reduce -25.58%3,500,000
MRKRichard Pzena 2016-03-31 Buy 0.3%$48.59 - $53.32
($51.31)
$ 58.8215%New holding921,365
MRKJoel Greenblatt 2016-03-31 Add0.29%$48.59 - $53.32
($51.31)
$ 58.8215%Add 65.71%1,248,557
MRKKahn Brothers 2016-03-31 Reduce-0.24%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -2.52%985,419
MRKT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.22%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -16.17%4,702,900
MRKVanguard Health Care Fund 2016-03-31 Reduce-0.18%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -3.46%48,728,100
MRKNWQ Managers 2016-03-31 Sold Out -0.06%$48.59 - $53.32
($51.31)
$ 58.8215%Sold Out0
MRKCharles Brandes 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -0.42%3,000,058
MRKKen Fisher 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -1.82%6,698,235
MRKMario Gabelli 2016-03-31 Reduce-0.01%$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -15.38%118,145
MRKFirst Eagle Investment 2016-03-31 Add$48.59 - $53.32
($51.31)
$ 58.8215%Add 106.55%16,090
MRKBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$48.59 - $53.32
($51.31)
$ 58.8215%Add 0.03%26,663,511
MRKDavid Dreman 2016-03-31 Buy $48.59 - $53.32
($51.31)
$ 58.8215%New holding710
MRKDodge & Cox 2016-03-31 Reduce$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -0.08%24,543,704
MRKRuane Cunniff 2016-03-31 Reduce$48.59 - $53.32
($51.31)
$ 58.8215%Reduce -2.00%4,894
MRKJoel Greenblatt 2015-12-31 Add0.43%$49.47 - $55.53
($52.9)
$ 58.8211%Add 12793.07%753,471
MRKT Rowe Price Equity Income Fund 2015-12-31 Reduce-0.21%$49.47 - $55.53
($52.89)
$ 58.8211%Reduce -14.63%5,610,000
MRKCharles Brandes 2015-12-31 Add0.17%$49.47 - $55.53
($52.9)
$ 58.8211%Add 7.90%3,012,572
MRKBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add0.12%$49.47 - $55.53
($52.9)
$ 58.8211%Add 5.86%26,655,176
MRKVanguard Health Care Fund 2015-12-31 Add0.08%$49.47 - $55.53
($52.9)
$ 58.8211%Add 1.47%50,476,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-07-05Sell45,000$57.991.43view
FRAZIER KENNETH CChairman, President & CEO 2016-07-05Sell60,000$581.41view
Schechter Adam HEVP & Pres-Global Human Health 2016-07-01Sell50,000$57.691.96view
GRADDICK WEIR MIRIAN MExe V-P, HR 2016-07-01Sell30,000$57.492.31view
Golestani ClarkEVP & Chief Info Officer 2016-05-20Sell39,877$54.797.36view
Holston Michael JEVP, General Counsel 2016-05-10Sell100,021$54.57.93view
FRAZIER KENNETH CChairman, President & CEO 2016-04-14Sell131,040$56.114.83view
WEEKS WENDELL PDirector 2015-11-04Sell5,000$55.535.92view
AMBROSE ADELE DSr.V-P & Chief Comuns Officer 2015-10-29Sell37,313$55.086.79view
FRAZIER KENNETH CChairman, President & CEO 2015-10-29Sell18,666$54.697.55view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

News about MRK:

Articles On GuruFocus.com
T. Rowe Price Equity Income Fund Sells Apache, Johnson & Johnson in 2nd Quarter Jul 21 2016 
Technology Earnings Helping Market to Gain Jul 20 2016 
An Unfair Valuation Makes a Great Investment Jul 15 2016 
5 Overvalued Dow Components Jul 15 2016 
Stocks Higher After Release of FOMC Minutes Jul 07 2016 
Merck CEO Sells 60,000 Company Shares Jul 06 2016 
Market Indexes Higher With Volatility Lower May 25 2016 
The PBM Empire Strikes Back May 10 2016 
U.S. Stocks Trade Flat at Start of Week May 09 2016 
Market Indexes Flat as Economic Indicators Still Point Lower May 08 2016 

More From Other Websites
The Economy, Interest Rates, Earnings and the Markets Jul 24 2016
7:03 am Merck announces data in previously untreated adults with HIV-1 infection for the company's... Jul 24 2016
5 Big Drugmakers Reporting Earnings Next Week Jul 22 2016
Eli Lilly, J&J, Novo Battle Diabetes -- And Each Other Jul 22 2016
Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS Jul 22 2016
Market Exclusive’s Inside the FDA: This Week Bezlotoxumab from Merck & Co., Inc. (MRK) Jul 22 2016
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at... Jul 22 2016
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at... Jul 22 2016
More Than 400 Women Are Now Suing Merck for Unequal Pay Jul 21 2016
Merck Animal Health Receives FDA Approval of BRAVECTO® (fluralaner topical solution) for Cats and... Jul 21 2016
Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent... Jul 21 2016
These 5 Big Stocks Are Breaking Out This Summer Jul 21 2016
Six Major Biotech Acquisitions You Could See In 2016 (Part 1) Jul 20 2016
U.S. healthcare stock bulls look past political risks Jul 20 2016
What's behind heavy put volume in Merck Jul 20 2016
Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape Jul 19 2016
Why a Trump Win Could Be Good News for Pfizer, IBM Jul 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)